Pain and analgesics

(329) Adverse Events of Drugs Used in Pain Therapies: An Analysis of Spontaneous Reports from Switzerland

(330) Analgesia Dispensing in Primary Care in Ireland and England - A Repeated Cross-Sectional Study

(331) Comparative risk of mortality in new users of prescription opioids for non-cancer pain: results from the International Pharmacosurveillence Study

(332) Antenatal depressive and anxiety symptoms in women with eating disorders who continue or discontinue antidepressant treatment in pregnancy - results from the Norwegian Mother, Father, and Child Cohort Study

(333) Fatal intoxications with paracetamol in Sweden – a majority of fatalities had a prescription

(334) Impact of pharmacovigilance interventions targeting diclofenac on pain medication use in the United Kingdom

(336) Prevalence and risk factors associated with adverse drug reactions to propofol used during interventional endoscopic procedures in a Peruvian population: cross-sectional study

(337) Prevalence, characteristics, and prescription pain medication use in the osteoarthritis population

(338) Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain

(339) Risk of lower extremity injury following concussion in the National Football League

(340) Self-reported physical functioning in patients with chronic low back pain (CLBP)